Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

A. H.Jan Danser*, Murray Epstein, Daniel Batlle

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

391 Scopus citations

Fingerprint

Dive into the research topics of 'Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

INIS

Immunology and Microbiology